Join the 'Hyperimmunoglobulin D Syndrome' group to help and get support from people like you.
Hyperimmunoglobulin D Syndrome News
Related terms: HIDS, Mevalonate Kinase Deficiency, MKD, Hyperimmunoglobulin D Periodic Fever Syndrome
Posted 26 Sep 2016 by Drugs.com
September 23, 2016 – The U.S. Food and Drug Administration today approved three new indications for Ilaris (canakinumab). The new indications are for rare and serious auto-inflammatory diseases in adult and pediatric patients: Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS); Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate Kinase Deficiency (MKD); and Familial Mediterranean ...